Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
107.81
-0.15 (-0.14%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Abbott Laboratories Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 46,585 | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 |
Revenue Growth | 8.06% | 5.67% | 4.59% | -8.12% | 1.34% | 24.46% |
Gross Profit Gross Profit Growth | 26,373 | 25,009 | 23,244 | 22,134 | 24,511 | 24,538 |
Operating Income Operating Income Growth | 7,346 | 8,053 | 6,825 | 6,478 | 8,362 | 8,425 |
Net Income Net Income Growth | 5,425 | 6,524 | 13,402 | 5,723 | 6,933 | 7,071 |
Earnings Per Share EPS Growth | 3.09 | 3.72 | 7.64 | 3.26 | 3.91 | 3.94 |
EPS Growth | -61.28% | -51.31% | 134.36% | -16.62% | -0.76% | 57.60% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Established Pharmaceutical Products Established Pharmaceutical Products Growth | 5,818 | 5,536 | 5,194 | 5,066 | 4,912 | 4,718 |
Nutritionals Nutritionals Growth | 8,254 | 8,451 | 8,413 | 8,154 | 7,459 | 8,294 |
Diagnostics Diagnostics Growth | 9,982 | 8,937 | 9,341 | 9,988 | 16,469 | 15,526 |
Medical Devices Medical Devices Growth | 22,515 | 21,387 | 18,986 | 16,887 | 14,802 | 14,485 |
Other Segment Other Segment Growth | 16 | 17 | 16 | 14 | 11 | 52 |
Revenue (Total) Revenue (Total) Growth | 46,585 | 44,328 | 41,950 | 40,109 | 43,653 | 43,075 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,603 | 8,939 | 7,967 | 7,279 | 10,170 | 10,249 |
Total Debt Total Debt Growth | 32,608 | 12,929 | 14,125 | 14,679 | 16,773 | 18,050 |
Net Cash (Debt) Net Cash Growth | -27,005 | -3,990 | -6,158 | -7,400 | -6,603 | -7,801 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -15.46 | -2.28 | -3.52 | -4.23 | -3.74 | -4.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 9,905 | 9,566 | 8,558 | 7,261 | 9,581 | 10,533 |
Capital Expenditures CapEx Growth | -2,081 | -2,171 | -2,207 | -2,202 | -1,777 | -1,885 |
Free Cash Flow Free Cash Flow Growth | 7,824 | 7,395 | 6,351 | 5,059 | 7,804 | 8,648 |
Free Cash Flow Growth | 15.48% | 16.44% | 25.54% | -35.17% | -9.76% | 51.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.61% | 56.42% | 55.41% | 55.18% | 56.15% | 56.97% |
Operating Margin | 15.77% | 18.17% | 16.27% | 16.15% | 19.16% | 19.56% |
Pretax Margin | 16.12% | 19.10% | 16.72% | 16.61% | 19.03% | 19.06% |
Profit Margin | 11.65% | 14.72% | 31.95% | 14.27% | 15.88% | 16.42% |
FCF Margin | 16.80% | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.520 | 2.400 | 2.240 | 2.080 | 1.920 | 1.820 |
Dividend Per Share Growth | 6.90% | 7.14% | 7.69% | 8.33% | 5.50% | 18.95% |
Dividend Yield | 2.34% | 1.89% | 1.95% | 1.86% | 1.72% | 1.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.88 | 33.68 | 14.81 | 33.76 | 28.08 | 35.72 |
Forward PE | 18.59 | 22.63 | 22.39 | 24.22 | 26.64 | 30.05 |
P/FCF Ratio | 23.84 | 29.42 | 30.84 | 37.73 | 24.45 | 28.71 |
PS Ratio | 4.00 | 4.91 | 4.67 | 4.76 | 4.37 | 5.76 |